FDA Recall United States TerminatedTerminated: October 15, 2020Historical recordClass III
Barlean's Llc
- Product
- Item FG 10079, Barleans, Flax Oil, 100 Softgels per bottle.…
- Published
- May 22, 2019
- Distribution
- Nationwide
United States
TerminatedClass III
Barlean's dietary supplement product is recalled due to undeclared Sulfites. Sulfite levels of finished goods does not exceed 10 ppm.
| Product description | UPC | Quantity | Lot / code information |
|---|---|---|---|
| Item FG 10190, Barleans Full Spectrum Hemp Extract, 60 Softgels per bottle. UPC 7 05875 80113 3. Item FG 10193, Barleans Full Spectrum Hemp Extract, 30 Softgels per bottle. UPC 7 05875 80115 7. | Not published in this source record | firm did not provide | Best By of January 2021 and earlier |
This recall shares FDA event ID 82565 with 9 other product entries in Public Health Trace.
FDA Recall United States TerminatedTerminated: October 15, 2020Historical recordClass III
FDA Recall United States TerminatedTerminated: October 15, 2020Historical recordClass III
FDA Recall United States TerminatedTerminated: October 15, 2020Historical recordClass III
FDA Recall United States TerminatedTerminated: October 15, 2020Historical recordClass III
FDA Recall United States TerminatedTerminated: October 15, 2020Historical recordClass III
FDA Recall United States TerminatedTerminated: October 15, 2020Historical recordClass III
FDA Recall United States TerminatedTerminated: October 15, 2020Historical recordClass III
FDA Recall United States TerminatedTerminated: October 15, 2020Historical recordClass III
FDA Recall United States TerminatedTerminated: October 15, 2020Historical recordClass III
Responsible company: Barlean's Llc
FDA Recall United States TerminatedTerminated: October 15, 2020Historical recordClass III
FDA Recall United States TerminatedTerminated: October 15, 2020Historical recordClass III
FDA Recall United States TerminatedTerminated: October 15, 2020Historical recordClass III
View FDA enforcement record -- the specific openFDA record this summary was built from.
This record comes from FDA's Enforcement Report database. Not every Enforcement Report record has a separate FDA.gov recall-announcement page.
FDA Enforcement Reports -- FDA's general, official recall and enforcement information. See FDA Enforcement Reports versus recall announcements for how that database differs from a press-release-style announcement.
New to reading a recall record? See how to read an FDA recall record and what recall statuses mean.
View raw source data -- the machine-readable record this page's information was built from.
Retrieved by Public Health Trace:
FDA classifies this recall as Class III. See how to read an FDA recall record (linked above) for what each classification level means.
According to FDA, this recall's status is "Terminated." Always confirm the current status using the source links below, since status can change after Public Health Trace last retrieved this record.
Follow the responsible agency's published instructions, linked below -- recall guidance is set by that agency, not by Public Health Trace.
Public Health Trace does not provide medical advice -- review the linked official source below for current, authoritative information.
This record is preserved as published by FDA, as of October 15, 2020.
Status as reported: Terminated.
This page does not imply a current danger or a current consumer instruction -- review the official source for the most current information.
This summary is based on the official source record referenced above. Public Health Trace does not state that any company or product is unsafe beyond what the official source has published. Read the full medical disclaimer.
Reconnecting to the server…
We lost the connection to the server.
Your session has expired.